Select Page
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts containing a targeted Hutchinson-Gil

abcnews.com Healthology Article Highlights Latest Findings

Reporter Christine Haran provides a top-line overview of Progeria and the current research findings reported in Nature and Journal of Pediatrics. Reporter Christine Haran provides a top-line overview of Progeria and the current research findings reported in Nature and...
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts containing a targeted Hutchinson-Gil

Exciting News on Potential Drug Treatments

August 2005 –February 2006: Researchers have published studies that support a potential drug treatment for children with Progeria. Farnesyltransferase inhibitors (FTIs), originally developed for cancer, are capable of reversing the dramatic nuclear structure...

Dr. Leslie Gordon Interviewed on CNN

  Millions tuned in to CNN Live Weekend on Saturday, February 5th to watch a captivating interview with PRF Medical Director Dr. Leslie Gordon. CNN Anchor Christine Romans described it as “one mother’s mission to help her son and others afflicted with...
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts containing a targeted Hutchinson-Gil

Racing with Sam

The January 30th issue of the New York Times Magazine features the compelling story of PRF Medical Director Dr. Leslie Gordon, her husband Dr. Scott Berns, and their son Sam. The story, “Racing with Sam,” highlights the challenges faced by the Gordon and Berns family...
PRF Featured by Healthy Mothers, Healthy Babies Coalition

PRF Featured by Healthy Mothers, Healthy Babies Coalition

Each month the HMHB website features a personal Question & Answer interview with experts in the fields of maternal and child health. PRF Medical Director Leslie Gordon shared PRF’s story in the April edition. Click on this link and Learn About...
en_USEnglish